Literature DB >> 31229970

Drug-resistant epilepsy, early-onset hypertension and white matter lesions: a hidden paraganglioma.

Katri Silvennoinen1,2, Alison J Waghorn3, Simona Balestrini1,2, Sanjay M Sisodiya1,2.   

Abstract

We describe the case of a 35-year-old man with focal epilepsy since age 16. Due to a refractory course, several treatments were tried over the years, including insertion of a deep brain stimulator. At the time of his first assessment at our unit, he had recently been diagnosed with hypertension. An MR scan of brain revealed multiple T2 hyperintense white matter lesions, and evidence of previous haemorrhage in the left basal ganglia and pons. On follow-up imaging, the changes were considered to be in keeping with hypertensive arteriopathy. He was referred for further assessment of his hypertension and was found to have a para-aortic paraganglioma. This was excised 16 months after his initial presentation to us. The surgery was associated with an improvement in his seizure control. This case serves as a reminder of the need to be vigilant about the possibility of coexisting conditions in people with epilepsy. © BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  epilepsy and seizures; hypertension

Mesh:

Substances:

Year:  2019        PMID: 31229970      PMCID: PMC6605913          DOI: 10.1136/bcr-2018-228348

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

Review 1.  Comorbidities of epilepsy: current concepts and future perspectives.

Authors:  Mark R Keezer; Sanjay M Sisodiya; Josemir W Sander
Journal:  Lancet Neurol       Date:  2015-11-06       Impact factor: 44.182

2.  Epilepsy in neurofibromatosis type 1.

Authors:  Anthony Pecoraro; Eric Arehart; William Gallentine; Rodney Radtke; Edward Smith; Carolyn Pizoli; Sujay Kansagra; Elie Abdelnour; Roger McLendon; Mohamad A Mikati
Journal:  Epilepsy Behav       Date:  2017-07-18       Impact factor: 2.937

Review 3.  Prevalence and incidence of epilepsy: A systematic review and meta-analysis of international studies.

Authors:  Kirsten M Fiest; Khara M Sauro; Samuel Wiebe; Scott B Patten; Churl-Su Kwon; Jonathan Dykeman; Tamara Pringsheim; Diane L Lorenzetti; Nathalie Jetté
Journal:  Neurology       Date:  2016-12-16       Impact factor: 9.910

Review 4.  Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas.

Authors:  Jenny Welander; Peter Söderkvist; Oliver Gimm
Journal:  Endocr Relat Cancer       Date:  2011-12-01       Impact factor: 5.678

Review 5.  Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors.

Authors:  Edoardo Ferlazzo; Sara Gasparini; Ettore Beghi; Chiara Sueri; Emilio Russo; Antonio Leo; Angelo Labate; Antonio Gambardella; Vincenzo Belcastro; Pasquale Striano; Maurizio Paciaroni; Laura Rosa Pisani; Umberto Aguglia
Journal:  Epilepsia       Date:  2016-07-06       Impact factor: 5.864

6.  Anesthesia management of a ganglioneuroma with seizures presenting as pheochromocytoma.

Authors:  Yatindra Kumar Batra; Subramanyam Rajeev; Katragadda Ln Rao
Journal:  Paediatr Anaesth       Date:  2007-05       Impact factor: 2.556

7.  Seizures as a presenting symptom of phaeochromocytoma in a young soldier.

Authors:  A Leiba; Y Bar-Dayan; R R Leker; S Apter; E Grossman
Journal:  J Hum Hypertens       Date:  2003-01       Impact factor: 3.012

8.  Neurological manifestations of phaeochromocytomas and secretory paragangliomas: a reappraisal.

Authors:  Neil E Anderson; Kong Chung; Ernie Willoughby; Michael S Croxson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-01       Impact factor: 10.154

Review 9.  Stress and epilepsy: fact or fiction, and what can we do about it?

Authors:  Clare M Galtrey; Marco Mula; Hannah R Cock
Journal:  Pract Neurol       Date:  2016-03-01

Review 10.  Mechanisms underlying anticonvulsant and proconvulsant actions of norepinephrine.

Authors:  Maedeh Ghasemi; Nasrin Mehranfard
Journal:  Neuropharmacology       Date:  2018-05-11       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.